DISCORDANCE IN LEFT VENTRICULAR MASS INDEX BY CARDIAC MAGNETIC RESONANCE VERSUS ECHOCARDIOGRAPHY INCREASES IN HEART FAILURE  by Henkel, Danielle et al.
Imaging
E1238
JACC March 27, 2012
Volume 59, Issue 13
DISCORDANCE IN LEFT VENTRICULAR MASS INDEX BY CARDIAC MAGNETIC RESONANCE VERSUS 
ECHOCARDIOGRAPHY INCREASES IN HEART FAILURE
ACC Moderated Poster Contributions
McCormick Place South, Hall A
Saturday, March 24, 2012, 11:00 a.m.-Noon
Session Title: Imaging: MRI in Evaluation of Anatomy, Perfusion and Vasculature
Abstract Category: 21. Imaging: MRI
Presentation Number: 1089-171
Authors: Danielle Henkel, Nowell Fine, Sung-A Chang, Sang-Chul Lee, James Glockner, Eric Williamson, Yeon-Hyeon Choe, Jae Oh, Mayo Clinic, 
Rochester, MN, USA, Samsung Medical Center, Seoul, South Korea
Background:  Left ventricular mass index (LVMI) has prognostic importance in heart failure through association with geometric remodeling. 
Cardiac magnetic resonance (CMR) is considered a noninvasive gold standard modality for measurement of LV mass. The extent of variation in LV 
mass measurements by CMR versus transthoracic echocardiography (TTE) within a heart failure population is unknown.
Methods:  A prospective, international cardiac imaging study of 260 adults with systolic heart failure, diastolic heart failure, isolated hypertension 
or normal healthy control was undertaken in Seoul, South Korea and Rochester, MN from 2009-2011. TTE and CMR studies were performed <14 
days apart. TTE derived LV mass was calculated using 2D linear measurements, modeling the LV as a prolate ellipse. CMR LV mass was estimated by 
semiautomated tracings of myocardial volume in short axis SSPF series, excluding the papillary muscles.
Results:  Paired mean LVMI values by CMR and TTE were significantly different and had poor correlation in the entire cohort and subgroup analysis 
(Table). Discrepancies in LVMI measurements increased in heart failure subgroups versus controls (p<0.001). Interobserver agreement was superior 
in CMR LVMI (ICC 0.965, 95% CI 0.916-0.985) compared with TTE LVMI (ICC 0.869, 95% CI 0.06-0.982).
Conclusion:  Paired LVMI measurements by CMR versus TTE are significantly different and have poor correlation; a finding amplified in heart failure 
patients and thus relevant for clinical practice.  
CMR
LVMI ± SEM (g/
m2)
TTE LVMI ± SEM 
(g/m2)
Difference of means ± SEM 
(p value)
(g/m2)
Pearson coefficient
Concordance correlation 
coefficient
(95% CI)
Entire cohort (n=260) 62.5 ± 1.2 98.7 ± 2.4 37.1 ± 1.8 p<0.001 0.674
0.315
(0.263-0.366)
Healthy control, age < 40 yrs 
(n=36)
50.9 ± 2.0 67.8 ± 2.8 16.9 ± 2.3 p<0.001 0.589
0.036
(-0.072-0.144)
Healthy control, age ≥ 40 yrs 
(n=57)
50.1 ± 1.2 72.6 ± 1.9 22.5 ± 1.9 p<0.001 0.318
0.108
(0.019-0.195)
Hypertension (n=38) 58.5 ± 2.3 82.7 ± 3.6 24.3 ± 3.6 p<0.001 0.256
0.134
(-0.026-0.287)
Heart failure, normal ejection 
fraction (n=71)
74.9 ± 2.2 137.8 ± 3.9 62.9 ± 3.6 p<0.001 0.450
0.104
(0.047-0.160)
Systolic heart failure, ischemic 
(n=32)
74.7 ± 3.1 119 ± 4.4 44.3 ± 5.5 p<0.001 0.326
0.102
(-0.03-0.230)
Systolic heart failure,
nonischemic (n=28)
60.3 ± 4.7 96.7 ± 8.5 36.6 ± 5.1 p<0.001 0.830
0.467
(0.287-0.615)
